Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced that twelve presentations following expansive research in amyotrophic lateral sclerosis (ALS) will be shared as part of the Northeast ...
Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced two presentations at the 2024 National Association of Specialty Pharmacy (NASP) Annual Meeting and expo being held in Nashville, T.N., ...
Based on animal data, RADICAVA and RADICAVA ORS may cause fetal harm. To report suspected adverse reactions or product complaints, contact Mitsubishi Tanabe Pharma America, Inc., at 1-888-292-0058 ...
Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the presentation of real-world data from a retrospective analysis of healthcare resource utilization (HCRU) among people with amyotrophic ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...